Metabolic reprogramming in osteoclasts

被引:0
|
作者
Kyung-Hyun Park-Min
机构
[1] Hospital for Special Surgery,Arthritis and Tissue Degeneration Program, David Z. Rosensweig Genomics Research Center
[2] Weill Cornell Medical College,Department of Medicine
[3] Weill Cornell Graduate School of Medical Sciences,BCMB Allied Program
来源
关键词
Osteoclasts; Metabolism; Metabolic reprogramming;
D O I
暂无
中图分类号
学科分类号
摘要
Osteoclasts are bone-resorbing cells that play an essential role in the remodeling of the bone. Defects in osteoclasts thus result in unbalanced bone remodeling, leading to numerous pathological conditions such as osteoporosis, bone metastasis, and inflammatory bone erosion. Metabolism is any process a cell utilizes to meet its energetic demand for biological functions. Along with signaling pathways and osteoclast-specific gene expression programs, osteoclast differentiation activates metabolic programs. The energy generated from metabolic reprogramming in osteoclasts not only supports the phenotypic changes from mononuclear precursor cells to multinuclear osteoclasts, but also facilitates bone resorption, a major function of terminally differentiated, mature osteoclasts. While oxidative phosphorylation is studied as a major metabolic pathway that fulfills the energy demands of osteoclasts, all metabolic pathways are closely interconnected. Therefore, it remains important to understand the various aspects of osteoclast metabolism, including the roles and effects of glycolysis, glutaminolysis, fatty acid synthesis, and fatty acid oxidation. Targeting the pathways associated with metabolic reprogramming has shown beneficial effects on pathological conditions. As a result, it is clear that a deeper understanding of metabolic regulation in osteoclasts will offer broader translational potential for the treatment of human bone disorders.
引用
收藏
页码:565 / 572
页数:7
相关论文
共 50 条
  • [1] Metabolic reprogramming in osteoclasts
    Park-Min, Kyung-Hyun
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (05) : 565 - 572
  • [2] Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
    Taubmann, Jule
    Krishnacoumar, Brenda
    Boehm, Christina
    Faas, Maria
    Mueller, Dorothea I. H.
    Adam, Susanne
    Stoll, Cornelia
    Boettcher, Martin
    Mougiakakos, Dimitrios
    Sonnewald, Uwe
    Hofmann, Joerg
    Schett, Georg
    Kroenke, Gerhard
    Scholtysek, Carina
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
    Jule Taubmann
    Brenda Krishnacoumar
    Christina Böhm
    Maria Faas
    Dorothea I. H. Müller
    Susanne Adam
    Cornelia Stoll
    Martin Böttcher
    Dimitrios Mougiakakos
    Uwe Sonnewald
    Jörg Hofmann
    Georg Schett
    Gerhard Krönke
    Carina Scholtysek
    [J]. Scientific Reports, 10
  • [4] Metabolic reprogramming in cholangiocarcinoma
    Raggi, Chiara
    Taddei, Maria Letizia
    Rae, Colin
    Braconi, Chiara
    Marra, Fabio
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (03) : 849 - 864
  • [5] Metabolic Reprogramming in Glioma
    Strickland, Marie
    Stoll, Elizabeth A.
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2017, 5
  • [6] Metabolic reprogramming of the tumor
    L M R Ferreira
    A Hebrant
    J E Dumont
    [J]. Oncogene, 2012, 31 : 3999 - 4011
  • [7] Metabolic reprogramming of the tumor
    Ferreira, L. M. R.
    Hebrant, A.
    Dumont, J. E.
    [J]. ONCOGENE, 2012, 31 (36) : 3999 - 4011
  • [8] Metabolic reprogramming and metabolic dependency in T cells
    Wang, Ruoning
    Green, Douglas R.
    [J]. IMMUNOLOGICAL REVIEWS, 2012, 249 : 14 - 26
  • [9] Metabolic Reprogramming in Cardiovascular Diseases
    Gao, Juan
    Zhu, Yujiao
    Bei, Yihua
    [J]. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2024, 17 (01) : 33 - 35
  • [10] Metabolic reprogramming in macrophage responses
    Yang Liu
    Ruyi Xu
    Huiyao Gu
    Enfan Zhang
    Jianwei Qu
    Wen Cao
    Xi Huang
    Haimeng Yan
    Jingsong He
    Zhen Cai
    [J]. Biomarker Research, 9